BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 28928175)

  • 1. Integrated management of atrial fibrillation including tailoring of anticoagulation in primary care: study design of the ALL-IN cluster randomised trial.
    van den Dries CJ; Oudega R; Elvan A; Rutten FH; van de Leur SJCM; Bilo HJG; Hoes AW; Moons KGM; Geersing GJ
    BMJ Open; 2017 Sep; 7(9):e015510. PubMed ID: 28928175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated management of atrial fibrillation in primary care: results of the ALL-IN cluster randomized trial.
    van den Dries CJ; van Doorn S; Rutten FH; Oudega R; van de Leur SJCM; Elvan A; Oude Grave L; Bilo HJG; Moons KGM; Hoes AW; Geersing GJ
    Eur Heart J; 2020 Aug; 41(30):2836-2844. PubMed ID: 32112556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring the effect of nurse practitioner (NP)-led care on health-related quality of life in adult patients with atrial fibrillation: study protocol for a randomized controlled trial.
    Smigorowsky MJ; Norris CM; McMurtry MS; Tsuyuki RT
    Trials; 2017 Aug; 18(1):364. PubMed ID: 28774317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation.
    Hendriks JM; de Wit R; Crijns HJ; Vrijhoef HJ; Prins MH; Pisters R; Pison LA; Blaauw Y; Tieleman RG
    Eur Heart J; 2012 Nov; 33(21):2692-9. PubMed ID: 22453654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation.
    Guo Y; Lane DA; Wang L; Zhang H; Wang H; Zhang W; Wen J; Xing Y; Wu F; Xia Y; Liu T; Wu F; Liang Z; Liu F; Zhao Y; Li R; Li X; Zhang L; Guo J; Burnside G; Chen Y; Lip GYH;
    J Am Coll Cardiol; 2020 Apr; 75(13):1523-1534. PubMed ID: 32241367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of cardiac and non-cardiac adverse events in community-dwelling older patients with atrial fibrillation: a prospective cohort study in the Netherlands.
    van Doorn S; Tavenier A; Rutten FH; Hoes AW; Moons KGM; Geersing GJ
    BMJ Open; 2018 Aug; 8(8):e021681. PubMed ID: 30139900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective randomised trial examining the impact of an educational intervention versus usual care on anticoagulation therapy control based on an SAMe-TT
    Phrommintikul A; Nathisuwan S; Gunaparn S; Krittayaphong R; Wongcharoen W; Sehmi S; Mehta S; Winkles N; Brocklehurst P; Mathers J; Jowett S; Jolly K; Lane D; Thomas GN; Lip GYH;
    BMJ Open; 2021 Oct; 11(10):e051987. PubMed ID: 34635526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of a specialized atrial fibrillation clinic vs. usual care in patients with atrial fibrillation.
    Hendriks J; Tomini F; van Asselt T; Crijns H; Vrijhoef H
    Europace; 2013 Aug; 15(8):1128-35. PubMed ID: 23515338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nurse-coordinated integrated care model to support decision-making and self-care in patients with atrial fibrillation: A study protocol.
    Li PWC; Yu DSF; Yan BBY
    J Adv Nurs; 2019 Dec; 75(12):3749-3757. PubMed ID: 31350778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of Implementing a Mobile Health-Technology Supported Pathway on Atrial Fibrillation-Related Adverse Events Among Patients With Multimorbidity: The mAFA-II Randomized Clinical Trial.
    Yao Y; Guo Y; Lip GYH;
    JAMA Netw Open; 2021 Dec; 4(12):e2140071. PubMed ID: 34932104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and rationale of DUTCH-AF: a prospective nationwide registry programme and observational study on long-term oral antithrombotic treatment in patients with atrial fibrillation.
    Chu G; Seelig J; Trinks-Roerdink EM; van Alem AP; Alings M; van den Bemt B; Boersma LV; Brouwer MA; Cannegieter SC; Ten Cate H; Kirchhof CJ; Crijns HJ; van Dijk EJ; Elvan A; van Gelder IC; de Groot JR; den Hartog FR; de Jong JS; de Jong S; Klok FA; Lenderink T; Luermans JG; Meeder JG; Pisters R; Polak P; Rienstra M; Smeets F; Tahapary GJ; Theunissen L; Tieleman RG; Trines SA; van der Voort P; Geersing GJ; Rutten FH; Hemels ME; Huisman MV
    BMJ Open; 2020 Aug; 10(8):e036220. PubMed ID: 32843516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel integrated care concept (NICC) versus standard care in the treatment of chronic cardiovascular diseases: protocol for the randomized controlled trial CardioCare MV.
    Schmidt C; Öner A; Mann M; Krockenberger K; Abbondanzieri M; Brandewiede B; Brüge A; Hostenkamp G; Kaiser A; Neumeyer H; Ziegler A
    Trials; 2018 Feb; 19(1):120. PubMed ID: 29458404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mobile phones in cryptogenic strOke patients Bringing sIngle Lead ECGs for Atrial Fibrillation detection (MOBILE-AF): study protocol for a randomised controlled trial.
    Treskes RW; Gielen W; Wermer MJ; Grauss RW; van Alem AP; Dehnavi RA; Kirchhof CJ; van der Velde ET; Maan AC; Wolterbeek R; Overbeek OM; Schalij MJ; Trines SA
    Trials; 2017 Aug; 18(1):402. PubMed ID: 28851409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated specialized atrial fibrillation clinics reduce all-cause mortality: post hoc analysis of a randomized clinical trial.
    Hendriks JML; Tieleman RG; Vrijhoef HJM; Wijtvliet P; Gallagher C; Prins MH; Sanders P; Crijns HJGM
    Europace; 2019 Dec; 21(12):1785-1792. PubMed ID: 31390464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated Risk Assessment for Stroke in Atrial Fibrillation (AURAS-AF)--an automated software system to promote anticoagulation and reduce stroke risk: study protocol for a cluster randomised controlled trial.
    Holt TA; Fitzmaurice DA; Marshall T; Fay M; Qureshi N; Dalton AR; Hobbs FD; Lasserson DS; Kearley K; Hislop J; Jin J
    Trials; 2013 Nov; 14():385. PubMed ID: 24220602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and rationale of a randomised controlled trial comparing apixaban to phenprocoumon in patients with atrial fibrillation on chronic haemodialysis: the AXADIA-AFNET 8 study.
    Reinecke H; Jürgensmeyer S; Engelbertz C; Gerss J; Kirchhof P; Breithardt G; Bauersachs R; Wanner C
    BMJ Open; 2018 Sep; 8(9):e022690. PubMed ID: 30206088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of oral anticoagulant therapy in acute ischemic stroke with atrial fibrillation: study protocol for a registry-based randomised controlled trial.
    Åsberg S; Hijazi Z; Norrving B; Terént A; Öhagen P; Oldgren J
    Trials; 2017 Dec; 18(1):581. PubMed ID: 29197413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shared decision making for stroke prevention in atrial fibrillation: study protocol for a randomized controlled trial.
    Kunneman M; Branda ME; Noseworthy PA; Linzer M; Burnett B; Dick S; Spencer-Bonilla G; Fernandez CA; Gorr H; Wambua M; Keune S; Zeballos-Palacios C; Hargraves I; Shah ND; Montori VM
    Trials; 2017 Sep; 18(1):443. PubMed ID: 28962662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the impact of implementing an integrated care management approach with Atrial fibrillation Better Care (ABC) pathway for patients with atrial fibrillation in England from 2020 to 2040.
    Camacho EM; Lip GYH
    Eur Heart J Qual Care Clin Outcomes; 2024 Jun; 10(4):326-333. PubMed ID: 37697684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial.
    Kirchhof P; Breithardt G; Camm AJ; Crijns HJ; Kuck KH; Vardas P; Wegscheider K
    Am Heart J; 2013 Sep; 166(3):442-8. PubMed ID: 24016492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.